175 related articles for article (PubMed ID: 12799206)
1. Induction of allograft tolerance through costimulatory blockade: first selection of drugs in vitro.
Vierboom MP; Ossevoort M; Sick EA; Haanstra K; Jonker M
Transpl Immunol; 2003; 11(2):215-22. PubMed ID: 12799206
[TBL] [Abstract][Full Text] [Related]
2. Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates.
Haanstra KG; Ringers J; Sick EA; Ramdien-Murli S; Kuhn EM; Boon L; Jonker M
Transplantation; 2003 Mar; 75(5):637-43. PubMed ID: 12640302
[TBL] [Abstract][Full Text] [Related]
3. Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys.
Bîrsan T; Hausen B; Higgins JP; Hubble RW; Klupp J; Stalder M; Celniker A; Friedrich S; O'Hara RM; Morris RE
Transplantation; 2003 Jun; 75(12):2106-13. PubMed ID: 12829920
[TBL] [Abstract][Full Text] [Related]
4. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys.
Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; 't Hart BA; Boon L; Jonker M
Transplantation; 2006 Nov; 82(9):1194-201. PubMed ID: 17102771
[TBL] [Abstract][Full Text] [Related]
5. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.
Judge TA; Wu Z; Zheng XG; Sharpe AH; Sayegh MH; Turka LA
J Immunol; 1999 Feb; 162(4):1947-51. PubMed ID: 9973463
[TBL] [Abstract][Full Text] [Related]
6. Effect of CD80 and CD86 blockade and anti-interleukin-12 treatment on mouse acute graft-versus-host disease.
Saito K; Yagita H; Hashimoto H; Okumura K; Azuma M
Eur J Immunol; 1996 Dec; 26(12):3098-106. PubMed ID: 8977310
[TBL] [Abstract][Full Text] [Related]
7. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.
Ossevoort MA; Ringers J; Kuhn EM; Boon L; Lorré K; van den Hout Y; Bruijn JA; de Boer M; Jonker M; de Waele P
Transplantation; 1999 Oct; 68(7):1010-8. PubMed ID: 10532543
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of murine corneal allograft rejection by treatment with antibodies to CD80 and CD86.
Kagaya F; Hori J; Kamiya K; Kaji Y; Oshika T; Amano S; Yamagami S; Tsuru T; Tanaka S; Matsuda H; Yagita H; Okumura K
Exp Eye Res; 2002 Jan; 74(1):131-9. PubMed ID: 11878826
[TBL] [Abstract][Full Text] [Related]
9. The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis.
Tsai MK; Ho HN; Chien HF; Ou-Yang P; Lee CJ; Lee PH
Transplantation; 2004 Jan; 77(1):48-54. PubMed ID: 14724434
[TBL] [Abstract][Full Text] [Related]
10. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
Cai Y; Zhou PJ; Tang XD
Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
[TBL] [Abstract][Full Text] [Related]
11. Transient blocking of both B7.1 (CD80) and B7.2 (CD86) in addition to CD40-CD40L interaction fully abrogates the immune response following systemic injection of adenovirus vector.
Ziller C; Stoeckel F; Boon L; Haegel-Kronenberger H
Gene Ther; 2002 May; 9(9):537-46. PubMed ID: 11973629
[TBL] [Abstract][Full Text] [Related]
12. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
13. Association of rapamycin and co-stimulation blockade using anti-B7 antibodies in renal allotransplantation in baboons.
Boulday G; Ashton-Chess J; Bernard P; Karam G; Vié H; Moreau A; Minault D; Lorré K; Soulillou JP; Blancho G
Nephrol Dial Transplant; 2004 Jul; 19(7):1752-60. PubMed ID: 15069178
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys.
Haegel-Kronenberger H; Haanstra K; Ziller-Remy C; Ortiz Buijsse AP; Vermeiren J; Stoeckel F; Van Gool SW; Ceuppens JL; Mehtali M; De Boer M; Jonker M; Boon L
Gene Ther; 2004 Feb; 11(3):241-52. PubMed ID: 14737083
[TBL] [Abstract][Full Text] [Related]
15. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival.
Gorczynski RM; Cattral MS; Chen Z; Hu J; Lei J; Min WP; Yu G; Ni J
J Immunol; 1999 Aug; 163(3):1654-60. PubMed ID: 10415071
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
[TBL] [Abstract][Full Text] [Related]
17. Costimulation blockade of CD40 and CD28 pathways in limb transplantation.
Tung TH; Mackinnon SE; Mohanakumar T
Transplant Proc; 2008 Dec; 40(10):3723-4. PubMed ID: 19100474
[TBL] [Abstract][Full Text] [Related]
18. Identification of gene expression profile in tolerizing murine cardiac allograft by costimulatory blockade.
Matsui Y; Saiura A; Sugawara Y; Sata M; Naruse K; Yagita H; Kohro T; Mataki C; Izumi A; Yamaguchi T; Minami T; Sakihama T; Ihara S; Aburatani H; Hamakubo T; Kodama T; Makuuchi M
Physiol Genomics; 2003 Nov; 15(3):199-208. PubMed ID: 12966135
[TBL] [Abstract][Full Text] [Related]
19. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
[TBL] [Abstract][Full Text] [Related]
20. A novel fully human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys.
Imai A; Suzuki T; Sugitani A; Itoh T; Ueki S; Aoyagi T; Yamashita K; Taniguchi M; Takahashi N; Miura T; Shimamura T; Furukawa H; Todo S
Transplantation; 2007 Oct; 84(8):1020-8. PubMed ID: 17989608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
